WHO recommends monoclonal antibodies for patients at high risk of hospitalization |
Editorial
eMediNexus Coverage from: 
WHO recommends monoclonal antibodies for patients at high risk of hospitalization
Dr Veena Aggarwal, Consultant Womens’ Health, CMD and Editor-in-Chief, IJCP Group & Medtalks Trustee, Dr KK’s Heart Care Foundation of India,  27 September 2021
Coronavirus Live Count Map India

remove_red_eye 1282 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Multispeciality

6 Read Comments                

The World Health Organization (WHO) has recommended treatment with the combination of two monoclonal antibodies (casirivimab and imdevimab) for two groups of high-risk patients with Covid-19 in its latest living guidelines published in The BMJ.1 “Living guidelines are useful in fast moving research areas like Covid-19 because they allow researchers to update previously vetted and peer reviewed evidence summaries as new information becomes available.”These high-risk patients incl...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now